AZD-7762 is a selective inhibitor of checkpoint kinase (CHK) 1 and CHK2. It enhances sensitivity of urothelial carcinoma cells to gemcitabine through the inhibition of DNA repair checkpoints. It also works with gemcitabine to suppress the growth of KRAS-driven LKB1-deficient lung adenocarcinomas.
Uniformity of Dosage Units
Allschoolabs
Uniformity of Dosage Units is a specialised analytical laboratory service that assesses whether individual dosage units contain sufficiently consis...



































